Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR
Five independent predictors of long-term MB were identified in patients with AF requiring oral anticoagulant agents after TAVR and formed the HARHP score to assess MB risk. Use of the HARHP score may improve patient outcomes.
Authors
- Martin Unverdorben (ORCID: https://orcid.org/0000-0002-3601-8187)
- Johanna Van Zyl (ORCID: https://orcid.org/0000-0003-4205-9214)
- Tetsuya Kimura (ORCID: https://orcid.org/0000-0001-6367-7818)
- Johny Nicolas
- Roxana Mehran
- Diego López-Otero
- Stéphane Noble
- Christian Hengstenberg
- Peter Nordbeck
- Raúl Moreno
- Nicolas M. Van Mieghem
- George D. Dangas
- Hyo-Soo Kim
- Luis Nombela-Franco
- Cathy Chen
- Yusuke Watanabe
Institutions
- University of Geneva (CH)
- Hospital Universitario La Paz (ES)
- Erasmus MC (NL)
- Vienna General Hospital (AT)
- Seoul National University Hospital (KR)
- Hôpital Beau-Séjour (CH)
- Teikyo University Hospital (JP)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
- Mount Sinai Hospital (US)
- Daiichi-Sankyo (Japan) (JP)
- Universitätsklinikum Würzburg (DE)
- Complexo Hospitalario Universitario A Coruña (ES)
- Complejo Hospitalario de Pontevedra (ES)
- Daiichi Sankyo (United States) (US)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- JACC: Cardiovascular Interventions
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jcin.2025.11.028
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 30.07